The Biotech City

University of Montréal -
Laval Campus
1700, rue Jacques-Tétreault
Laval (Québec) Canada H7N 0B6

Keep record of the presentations. Please note that some speakers have decided not to give us a copy of their presentations.

Keynote Speakers
	Michael Houghton, Ph.D. Prospects for Prophylactic and Therapeutic Vaccines against the Hepatitis C Viruses
	Joe Cohen, Ph.D. Malaria Vaccine Development. Is there a Light at the End of the Tunnel?

Invited Speakers
	Jack Antel, M.D. Basis for Disease Progression in Multiple Sclerosis
	John Bell, Ph.D. Oncolytic Viruses for the Treatment of Cancer
	Michel Bouvier, Ph.D. Targeting G protein-coupled receptors folding and trafficking for the treatment of conformational diseases.
	Éric A. Cohen, Ph.D. Novel Insights into HIV-1-host interactions governing viral release and transmission
	Mark A. Wainberg, Ph.D. The development of resistance to anti-HIV drugs: clinical and epidemologic
	Alexandre Prat, Ph.D. Novel Adhesion Molecules Regulating the Trans-Endothelial Migration of Leukocytes


Samir Mounir, Ph.D., MBA	Pierre Talbot, Ph.D.
"Given the uncertain global economy, it is vital that the life sciences and health technology sector adopt new working methods to ensure that even the most extraordinary ideas become reality. Investors, governments and entrepreneurs must take part in this process of continuous improvement. This program was designed from this perspective."	"Society faces tremendous challenges in the area of health. Leading experts in basic and applied Research & Development, from both universities and industry, will present a state-of-the-art program and, together, explore some crucial scientific and business issues."